CRSP – Crispr Therapeutics AG
Investors holding1
Combined shares10,056,844
Combined reported value$556.3M
CRSP chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Cathie Wood | 3.20 | Added 6.3% | 10,056,844 | $556.3M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Cathie Wood | Added 6.3% | 10,056,844 | 0.19 |
| Q2 2026 | Cathie Wood | Reduced 16.4% | 9,460,939 | 0.66 |
| Q1 2026 | Cathie Wood | Added 7.5% | 11,313,623 | 0.29 |
| Q4 2025 | Cathie Wood | Added 7.5% | 10,522,057 | 0.26 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Cathie Wood | Added 6.3% | 10,056,844 | 0.19 |
| Q1 2026 | Cathie Wood | Added 7.5% | 11,313,623 | 0.29 |
| Q4 2025 | Cathie Wood | Added 7.5% | 10,522,057 | 0.26 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Cathie Wood | Reduced 16.4% | 9,460,939 | 0.66 |
History
1 peakQ3 2026: 1 tracked investors
20172026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | 10.06M | 9.46M | 11.31M | 10.52M | 9.79M | 10.18M | 10.17M | 8.97M |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).